SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas sharp selloff is being linked by traders to unconfirmed rumors of leaked Phase 3 melanoma-vaccine data and a YouTubers disclosed bearish put position; the community disputes whether either explains the move. Attention also centers on the forthcoming full trial readout, with bulls and bears debating whether expectations have run too high.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp drop alongside a broad semiconductor and Nasdaq selloff, with traders pointing to surging oil and concerns about AI-sector financing as possible pressures. The community is split between buying what many see as an oversold dip and warning that semiconductor weakness and the funds 3x leverage could extend losses.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias shares are sliding despite a quarterly earnings beat, as traders focus on lower cash-flow conversion expectations, higher restructuring costs, and rising supply-chain expenses. Bulls view the selloff as an overreaction to strong AI and cloud demand, while bears argue that cash generation and managements outlook outweigh the growth story.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp reversal after SpaceXs earnings has traders focused on insider share unlocks and the potential selling pressure as more shares become eligible to trade, wiping out the post-earnings gains. Bears see the supply overhang, high valuation and spending needs as risks, while bulls argue the weakness reflects broader market conditions and see the pullback as an opportunity.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

A sharp, volatile pullback in memory and semiconductor shares is driving attention, with traders linking the weakness to broader AI-trade jitters, capex concerns and selling across the sector ahead of SanDisks earnings. Bulls cite AI-driven NAND demand and expect results to support the shares, while bears argue the memory business remains cyclical and the selloff may continue.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas earnings beat was overshadowed by its higher AI infrastructure spending outlook, negative free cash flow, and concerns about how expansion may be financed, including a planned nonvoting share class. Traders are split between viewing the selloff as an overreaction to strong advertising results and seeing the spending and potential dilution as risks to returns.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a sharp Nasdaq and tech selloff, with traders focused on concerns about AI spending and funding, alongside Iran-related oil and market risks. The conversation is largely bearish, though some traders see oversold conditions and are looking for a rebound.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a sharp semiconductor selloff, with traders debating AI infrastructure spending and returns, geopolitical and oil-related macro fears, and weakness in Asian chip stocks. Bulls call the decline a sentiment-driven overshoot and point to strong memory demand, while bears warn that memorys cyclical nature could bring oversupply and further downside.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgents CFO departure has triggered a sharp selloff, with traders debating whether it reflects undisclosed financial concerns or is an overreaction to a personal transition. Some are calling for more clarity from management, while others point to the qualified internal successor and the companys growth outlook as reasons for optimism.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobes sharp rebound is being discussed as a rotation back into beaten-down software and an anti-AI trade, with some traders also calling it an oversold bounce or short squeeze. The rally has not eased the debate over whether AI tools and free software clones threaten Adobes business, while bulls point to its cash flow, established products and valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.read more...

Kura Oncology Q2 2026 Earnings Call Transcript

On Wednesday, Kura Oncology (NASDAQ:KURA) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
Benzinga APIs provide real-time access to earnings call transcriptsread more...

Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary

Kura Oncology launches Caspian Therapeutics with $50 million financing to advance menin inhibitor for diabetes and cardiometabolic diseases.read more...

Kura Oncology Names Jennifer Fulk CFO

(RTTNews) - Kura Oncology, Inc. (KURA), on Tuesday appointed Jennifer Fulk as Chief Financial Officer, effective September 8...

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Kura's rising Komzifti sales, promising AML data and pipeline catalysts boost investor confidence and fuel KURA's gains.

Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?

Kura Oncology (KURA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

 Company News for Aug 26, 2026

Companies in The News Are: DKS,KURA,NVTS,WMT

KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares — Retail Wonders If Wilson Is Following Moderna CEO’s Playbook

Equity

According to a filing with the SEC, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24 for about $1.24 million in total.


Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?

Key PointsThe President and CEO acquired ~100,000 shares at $12.39 per share for a total transaction value of $1.2 million...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Over eight days, Wilson has invested around $2.35 million in company stock.</li><li>The buying comes shortly after Kura reported second-quarter results showing early commercial traction for its approved drug KOMZIFTI.</li><li>A retail trader asked whether KURA stock is following the playbook of Moderna CEO Stéphane Bancel, who bought shares in March at a significant discount to the current price.</li></ul><p>Shares of Kura Oncology (KURA) closed 10% higher on Tuesday after hitting a fresh 52-week high above $13.90, as investors reacted to the company’s CEO buying more shares of the company.</p><p>The stock clocked its best day on Tuesday since May.</p><h2 class="st-heading-2">CEO Adds To Stake In Open-Market Buys</h2><p>According to an SEC filing, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24. The shares were acquired in multiple trades at prices ranging from $11.47 to $12.85, for a weighted average of $12.39—about $1.24 million in total. The shares are held through a trust.</p><p>This follows a similar purchase of an additional 100,000 shares on August 17 at a weighted-average price of $11.12. Over eight days, Wilson has invested around $2.35 million in company stock, a move widely seen as a vote of confidence.</p><h2 class="st-heading-2">Strong Start For Commercial Product</h2><p>The buying comes shortly after Kura reported second-quarter results showing early commercial traction for its approved drug KOMZIFTI. The therapy generated $9.1 million in net product sales, up 57% from the prior quarter. It has already captured a majority share of new patients in its approved use for certain relapsed or refractory blood cancers.</p><p>The company ended June with $519 million in cash and investments, plus expected partnership payments that will support operations for years to come.</p><h2 class="st-heading-2">Upcoming Data Readouts In Focus</h2><p>In the near term, attention is now on several clinical updates expected in the second half of 2026. These include longer-term results from combination studies of KOMZIFTI with standard treatments in newly diagnosed patients, initial data from pairings with other targeted therapies, and exploratory findings in additional patient groups. Progress on a second candidate, darlifarnib, in solid tumors also continues.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around KURA stock remained ‘bullish’ over the past 24 hours, while message volume was ‘extremely high.’</p><p>A Stocktwits user expressed optimism that the stock would eventually break resistance levels and explode.</p><p><stembedurl>https://stocktwits.com/AdiDasRom/message/662823669</stembedurl></p><p>Another asked whether the Kura CEO is following Moderna CEO’s playbook. Moderna (MRNA) CEO Stéphane Bancel last bought shares of the company on the open market in March for a total value of about $5 million. He bought the shares at a weighted average price of $31.22, and MRNA shares are currently trading at about $159.</p><p><stembedurl>https://stocktwits.com/Jtlo/message/662808425</stembedurl></p><p>A third user applauded the CEO for defending KURA’s stock price.</p><p><stembedurl>https://stocktwits.com/DCZ/message/662797244</stembedurl></p><p><a href="https://stocktwits.com/symbol/KURA">KURA stock</a> has gained 31% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-s-cybertruck-base-version-hits-74-990-nearly-2-x-its-2019-promised-price/cZYkCspRJoL">Tesla’s Cybertruck Base Version Hits $74,990 — Nearly 2X Its 2019 Promised Price</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the logo of Kura Oncology is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

According to a filing with the SEC, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24 for about $1.24 million in total.

Vanguard Total Stock Market ETF

SPDR S&P Biotech ETF

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$9.80
Prev Close	$9.88
Open	$9.81
Dividend Yield	0.00%
50-Day Moving Average	$11.32
Beta	1.19
Avg. Volume	1.81M
PE Ratio	-2.94

52-Week High	$13.90
52-Week Low	$7.36
Market Capitalization	$878.93M
EPS (Annual)	-$3.18
Price to Book	18.15
Revenue Per Employee	$259,546.15

Feed

News

Sentiment

Earnings

Fundamentals

Info

KURA Fundamentals